Fundamental Analysis

POLY MEDICURE 

Ticker : 531768 
BUY: Rs 300.05 
Target: Rs 335

Poly Medicure Limited manufactures disposable healthcare products. The company offers a wide range of products for infusion therapy, anaesthesia, urology, gastroenterology, blood management, surgery and drainage and catheters. It operates manufacturing facilities in Faridabad (Haryana), Jaipur (Rajasthan) and Haridwar (Uttarakhand). On a consolidated quarterly front, its net sales saw a decrease of 0.51 per cent to Rs 171.33 crore in Q4FY20 from Rs 172.21 crore in the same period for the previous fiscal year. The company reported a PBT of Rs 28.89 crore in Q4FY20, down by 1.96 per cent from Rs 29.47 crore in Q4FY19. The net profit of the company was reported at Rs 22.65 crore in Q4FY20, expanding by 5.05 per cent from Rs 21.56 crore in the corresponding quarter for the previous fiscal year. In the current economic environment, the healthcare and pharma sectors are poised to benefit the most in the fight against COVID-19. Thus, we recommend a BUY.